Profilo
Susan B. Stewart currently works at Regulatory Affairs Professionals Society, as Director, Candel Therapeutics, Inc., as Chief Regulatory Officer from 2020, and Rezolute, Inc., as Chief Regulatory Officer from 2022.
Ms. Stewart also formerly worked at MG Biotherapeutics LLC, as Director, VP-Quality & Regulatory Affairs in 2005, Abbott Laboratories, as Vice President-Regulatory Affairs, Diacrin, Inc. (Delaware), as Principal, Genzyme Corp., as Vice President-Regulatory Affairs from 2001 to 2005, Tokai Pharmaceuticals, Inc., as SVP-Regulatory Affairs, Quality & Compliance from 2009 to 2015, Kaleido Biosciences, Inc., as Chief Regulatory Officer from 2020 to 2022, Frequency Therapeutics, Inc., as Chief Regulatory Officer, resTORbio, Inc., as Head-Regulatory Affairs, and TransMolecular, Inc., as Vice President-Regulatory Affairs from 2005 to 2010.
Ms. Stewart received her undergraduate degree from the University of Massachusetts, graduate degree from Concord Law School, and graduate degree from Maurice A. Deane School of Law at Hofstra University.
Posizioni attive di Susan Stewart
| Società | Posizione | Inizio |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Consigliere Generale | 01/10/2020 |
| REZOLUTE, INC. | Consigliere Generale | 01/01/2022 |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Susan Stewart
| Società | Posizione | Fine |
|---|---|---|
| KORRO BIO, INC. | Consigliere Generale | 30/04/2023 |
| KALEIDO BIOSCIENCES, INC. | Consigliere Generale | 01/04/2022 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Responsabile della Conformità | 01/01/2015 |
TransMolecular, Inc.
TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Consigliere Generale | 01/01/2010 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Consigliere Generale | 01/01/2005 |
Formazione di Susan Stewart
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMolecular, Inc.
TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Health Technology |
MG Biotherapeutics LLC | |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Concord Law School
Concord Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Rezolute, Inc.
Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Maurice A. Deane School of Law at Hofstra University
Maurice A. Deane School of Law at Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
resTORbio, Inc.
resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
















